Cargando…

Imipramine Is an Orally Active Drug against Both Antimony Sensitive and Resistant Leishmania donovani Clinical Isolates in Experimental Infection

BACKGROUND: In an endeavor to find an orally active and affordable antileishmanial drug, we tested the efficacy of a cationic amphiphilic drug, imipramine, commonly used for the treatment of depression in humans. The only available orally active antileishmanial drug is miltefosine with long half lif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukherjee, Sandip, Mukherjee, Budhaditya, Mukhopadhyay, Rupkatha, Naskar, Kshudiram, Sundar, Shyam, Dujardin, Jean Claude, Das, Anjan Kumar, Roy, Syamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531496/ https://www.ncbi.nlm.nih.gov/pubmed/23301108 http://dx.doi.org/10.1371/journal.pntd.0001987

Ejemplares similares

Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy
por: Mukherjee, Sandip, et al.
Publicado: (2020)

A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs
por: Ghosh, Souradeepa, et al.
Publicado: (2021)

Restoration of IFNγR Subunit Assembly, IFNγ Signaling and Parasite Clearance in Leishmania donovani Infected Macrophages: Role of Membrane Cholesterol
por: Sen, Subha, et al.
Publicado: (2011)

The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice
por: Chowdhury, Sayan, et al.
Publicado: (2012)

Antimony Resistant Leishmania donovani but Not Sensitive Ones Drives Greater Frequency of Potent T-Regulatory Cells upon Interaction with Human PBMCs: Role of IL-10 and TGF-β in Early Immune Response
por: Guha, Rajan, et al.
Publicado: (2014)

Antimonial Resistance in Leishmania donovani Is Associated with Increased In Vivo Parasite Burden
por: Vanaerschot, Manu, et al.
Publicado: (2011)

Leishmania donovani Isolates with Antimony-Resistant but Not -Sensitive Phenotype Inhibit Sodium Antimony Gluconate-Induced Dendritic Cell Activation
por: Haldar, Arun Kumar, et al.
Publicado: (2010)

Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent
por: Dumetz, F., et al.
Publicado: (2018)

Mapping the Antigenicity of the Parasites in Leishmania donovani Infection by Proteome Serology
por: Forgber, Michael, et al.
Publicado: (2006)

Role of Efflux Pumps and Intracellular Thiols in Natural Antimony Resistant Isolates of Leishmania donovani
por: Rai, Smita, et al.
Publicado: (2013)

Modulation of Splenic B Cell Subsets during Experimental Leishmania donovani Infection in BALB/c Mice
por: Mondal, Koushik, et al.
Publicado: (2021)

Treatment of Visceral Leishmaniasis: Model-Based Analyses on the Spread of Antimony-Resistant L. donovani in Bihar, India
por: Stauch, Anette, et al.
Publicado: (2012)

Leishmania donovani Infection Enhances Lateral Mobility of Macrophage Membrane Protein Which Is Reversed by Liposomal Cholesterol
por: Ghosh, Moumita, et al.
Publicado: (2014)

Correction: Leishmania donovani Infection Enhances Lateral Mobility of Macrophage Membrane Protein Which Is Reversed by Liposomal Cholesterol
por: Ghosh, Moumita, et al.
Publicado: (2016)

Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani
por: Verma, Aditya, et al.
Publicado: (2017)

Zinc depletion promotes apoptosis-like death in drug-sensitive and antimony-resistance Leishmania donovani
por: Saini, Shalini, et al.
Publicado: (2017)

Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol
por: Hendrickx, Sarah, et al.
Publicado: (2012)

Cholesterol Corrects Altered Conformation of MHC-II Protein in Leishmania donovani Infected Macrophages: Implication in Therapy
por: Roy, Koushik, et al.
Publicado: (2016)

Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex
por: Downing, Tim, et al.
Publicado: (2012)

Seasonal Variation in the Prevalence of Sand Flies Infected with Leishmania donovani
por: Tiwary, Puja, et al.
Publicado: (2013)

Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress
por: Deep, Deepak Kumar, et al.
Publicado: (2017)

Identification of internalin-A-like virulent proteins in Leishmania donovani
por: Mukherjee, Ishita, et al.
Publicado: (2016)

Linking In Vitro and In Vivo Survival of Clinical Leishmania donovani Strains
por: Vanaerschot, Manu, et al.
Publicado: (2010)

Antimony resistance mechanism in genetically different clinical isolates of Indian Kala-azar patients
por: Khanra, Supriya, et al.
Publicado: (2022)

Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial
por: Picado, Albert, et al.
Publicado: (2010)

Global genome diversity of the Leishmania donovani complex
por: Franssen, Susanne U, et al.
Publicado: (2020)

Leishmania donovani-Induced Increase in Macrophage Bcl-2 Favors Parasite Survival
por: Pandey, Rajeev Kumar, et al.
Publicado: (2016)

Antimony Toxicity
por: Sundar, Shyam, et al.
Publicado: (2010)

Vaccine Development Against Leishmania donovani
por: Das, Amrita, et al.
Publicado: (2012)

Leishmania donovani Targets Dicer1 to Downregulate miR-122, Lower Serum Cholesterol, and Facilitate Murine Liver Infection
por: Ghosh, June, et al.
Publicado: (2013)

Leishmania Sores and Antimony
por: Narasimhan, N. S.
Publicado: (1918)

Risk Factors for Visceral Leishmaniasis and Asymptomatic Leishmania donovani Infection in India and Nepal
por: Picado, Albert, et al.
Publicado: (2014)

Integrative genomic, proteomic and phenotypic studies of Leishmania donovani strains revealed genetic features associated with virulence and antimony-resistance
por: Zheng, Zhiwan, et al.
Publicado: (2020)

Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani
por: Das, Sanchita, et al.
Publicado: (2015)

Latent Infection with Leishmania donovani in Highly Endemic Villages in Bihar, India
por: Hasker, Epco, et al.
Publicado: (2013)

Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs
por: Rastrojo, Alberto, et al.
Publicado: (2018)

On Transient Infections with Leishmania Donovani in Man and Animals
por: Knowles, R., et al.
Publicado: (1924)

A novel marker, ARM58, confers antimony resistance to Leishmania spp.()
por: Nühs, Andrea, et al.
Publicado: (2013)

Characterization of the DNA-binding domain and identification of the active site residue in the ‘Gyr A’ half of Leishmania donovani topoisomerase II
por: Sengupta, Tanushri, et al.
Publicado: (2005)

In Vitro Susceptibilities of Wild and Drug Resistant Leishmania donovani Amastigote Stages to Andrographolide Nanoparticle: Role of Vitamin E Derivative TPGS for Nanoparticle Efficacy
por: Mondal, Subhasish, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_70h8gg5jhpgm8g7q1fi25orpto